Air Products (APD)
NYSEMaterialsSpecialty ChemicalsSnapshot 2026-07-07
$305.04-1.24%
Close 2026-07-07 · 1-day change
Reading APD? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track APD free→NYSEMaterialsSpecialty ChemicalsSnapshot 2026-07-07
Reading APD? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track APD free→Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Materials: fringe margins under pressure (4q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Management is running behind on a stated commitment.
View ThesisRevenue is growing steadily — about 4% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 40%, softest on free-cash-flow margins.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskAir Products and Chemicals (APD) must maintain strong demand to justify its current price. Revenue grew 9% year over year in the latest quarter, beating expectations. It trades at 24× P/E, slightly above the peer median of 24×. This suggests the price reflects modest growth expectations compared to our view. A specific risk is the potential for a credibility hit if APD cuts guidance after raising it recently. Peer multiples imply a price about 10% below where it trades.
Trailing returns as of 2026-07-07. APD is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 23 analysts currently covering APD (as of Jul 2026).
Based on 7 Wall Street analysts offering 12-month price targets for APD in the last 4 months.
A consensus fair price across 10 valuation methods, at three horizons. Current price $305.04. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Materials (broad) — fair value, gap to price, and forward P/E.
Advances: Maintain capital expenditures at $4 billion
Facility expansion supports capital expenditure objectives.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-07. EPS is implied from price ÷ P/E. Not investment advice.
Current $305.04
The last 12 months of price, then the range of analyst 12-month targets from today’s $305.04.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Price target increase reflects positive earnings outlook.
Threatens: Maintain capital expenditures at $4 billion
CapEx discipline concerns could impact spending objectives.
Growth in industrial gas and semiconductor demand supports growth objectives.